11:11 AM EST - MediPharm Labs Corp. : Has entered into a multi-year supply agreement with Cronos Group Inc. MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18 months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24 months. In addition, Cronos Group has selected MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, as a preferred partner to fulfill certain of its processing needs, under a separate tolling arrangement. MediPharm Labs Corp.
shares V.LABS are trading up $0.64 at $7.07.
